Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Modulation of Prothrombinase Assembly and Activity by Phosphatidylethanolamine

Rinku Majumder, PhD, Xiaoe Liang, Ph.D, Mary Ann Quinn-Allen, William H. Kane, MD, PhD, Barry R. Lentz, PhD

Blood (2011) 118 (21): 4344.

https://doi.org/10.1182/blood.V118.21.4344.4344

Published: 2011

Journal Articles

Modulation of Prothrombinse Assembly and Activity by Phosphotidylethanolamine.

Rinku Majumder, PhD, Xiaoe Liang, Mary Ann Quinn-Allen, Barry R. Lentz, PhD, William H. Kane, MD, PhD

Blood (2009) 114 (22): 4207.

https://doi.org/10.1182/blood.V114.22.4207.4207

Published: 2009

Journal Articles

A phosphatidylserine binding site in factor V a C1 domain regulates both assembly and activity of the prothrombinase complex

Rinku Majumder, Mary Ann Quinn-Allen, William H. Kane, Barry R. Lentz

Blood (2008) 112 (7): 2795–2802.

https://doi.org/10.1182/blood-2008-02-138941

Published: 2008

Journal Articles

Localization of Stereo-Specific Phosphatidylserine Binding Sites within the Factor V C2 Domain.

Xiaoe Liang, PhD, Mary Ann Quinn-Allen, B.S., William H. Kane, M.D., Ph.D.

Blood (2007) 110 (11): 2701.

https://doi.org/10.1182/blood.V110.11.2701.2701

Published: 2007

Journal Articles

Identification of Amino Acid Residues in the C1 Domain of Human Factor V a2 That Affect Phosphatidylserine-Triggered Cofactor Activity.

Rinku Majumder, PhD, Mary Ann Quinn-Allen, Barry R. Lentz, Ph.D, William H. Kane

Blood (2006) 108 (11): 1711.

https://doi.org/10.1182/blood.V108.11.1711.1711

Published: 2006

Journal Articles

Cholesterol and Phosphatidylethanolamine Enhance the Binding of Factor Va and Factor Xa to Phospholipid Vesicles and Promote Assembly of the Prothrombinase Complex on Membranes Containing Low Concentrations of Phosphatidylserine.

Xiaoe Liang, PhD, Mary Ann Quinn-Allen, B.S., William H. Kane, M.D., Ph.D.

Blood (2006) 108 (11): 1712.

https://doi.org/10.1182/blood.V108.11.1712.1712

Published: 2006

Journal Articles

Factor V Binding to Multimerin 1: Modulation by Factor V Activation and Binding Sites in the Factor V C1 and C2 Domains.

Samira B. Jeimy, BSc, Mary Ann Quinn-Allen, B.Sc., Nola Fuller, M.Sc., Kenneth Segers, B.Sc., Alan R. Stafford, M.Sc., Jeffrey I. Weitz, M.D., Rodney M. Camire, Ph.D., Gerry A.F. Nicolaes, Ph.D., William H. Kane, M.D., Ph.D., Catherine P.M. Hayward, M.D., Ph.D.

Blood (2006) 108 (11): 193.

https://doi.org/10.1182/blood.V108.11.193.193

Published: 2006

Journal Articles

Human Platelets Contain Forms of Factor V in Disulfide-Linkage with Multimerin.

Catherine P.M. Hayward, MD PhD, Nola Fuller, MSc, Shilun Zheng, DVM MSc, Frederic Adam, PhD, Samira Jeimy, Ian Horsewood, Mary Ann Quinn-Allen, William H. Kane, MD PhD

Blood (2004) 104 (11): 1933.

https://doi.org/10.1182/blood.V104.11.1933.1933

Published: 2004

Journal Articles

Identification of the Multimerin Binding Region within the C2 Domain of Human Factor V Using Constructs Generated by Alanine-Scanning and Site-Directed Mutagenesis.

Samira B. Jeimy, B.Sc., Rachael A. Woram, M.Sc., Nola Fuller, M.Sc., Mary Anne Quinn-Allen, Gerard Nicolaes, Ph.D, Bjorn Dahlback, M.D., Ph.D., William H. Kane, M.D., Ph.D., Catherine P.M. Hayward, M.D., Ph.D.

Blood (2004) 104 (11): 124.

https://doi.org/10.1182/blood.V104.11.124.124

Published: 2004

Journal Articles

Mutation of the Hydrophobic Residues in Factor Va2 C1 Domain Affects the Phosphatidylserine Mediated Prothrombin Activation.

Rinku Majumder, PhD, Mary Ann Quinn-Allen, William H. Kane, PhD, Barry R. Lentz, PhD

Blood (2004) 104 (11): 1733.

https://doi.org/10.1182/blood.V104.11.1733.1733

Published: 2004

Journal Articles

Novel functional defect in factor V deficiency

William H. Kane

Blood (2003) 102 (4): 1150–1151.

https://doi.org/10.1182/blood-2003-06-1872

Published: 2003

Journal Articles

Inhibitory Anti–Factor V Antibodies Bind to the Factor V C2 Domain and Are Associated With Hemorrhagic Manifestations

Thomas L. Ortel, Karen D. Moore, Mary Ann Quinn-Allen, Takashi Okamura, Allen J. Sinclair, John Lazarchick, Ramaswamy Govindan, Françoise Carmagnol, William H. Kane

Blood (1998) 91 (11): 4188–4196.

https://doi.org/10.1182/blood.V91.11.4188

Published: 1998

Journal Articles

Studies of a Second Family With the Quebec Platelet Disorder: Evidence That the Degradation of the α-Granule Membrane and Its Soluble Contents Are Not Secondary to a Defect in Targeting Proteins to α-Granules

Catherine P.M. Hayward, Elisabeth M. Cramer, William H. Kane, Shilun Zheng, Madeleine Bouchard, Jean-Marc Massé, Georges E. Rivard

Blood (1997) 89 (4): 1243–1253.

https://doi.org/10.1182/blood.V89.4.1243

Published: 1997

NARROW

Modulation of Prothrombinase Assembly and Activity by Phosphatidylethanolamine

Modulation of Prothrombinse Assembly and Activity by Phosphotidylethanolamine.

A phosphatidylserine binding site in factor V a C1 domain regulates both assembly and activity of the prothrombinase complex

Localization of Stereo-Specific Phosphatidylserine Binding Sites within the Factor V C2 Domain.

Identification of Amino Acid Residues in the C1 Domain of Human Factor V a2 That Affect Phosphatidylserine-Triggered Cofactor Activity.

Cholesterol and Phosphatidylethanolamine Enhance the Binding of Factor Va and Factor Xa to Phospholipid Vesicles and Promote Assembly of the Prothrombinase Complex on Membranes Containing Low Concentrations of Phosphatidylserine.

Factor V Binding to Multimerin 1: Modulation by Factor V Activation and Binding Sites in the Factor V C1 and C2 Domains.

Human Platelets Contain Forms of Factor V in Disulfide-Linkage with Multimerin.

Identification of the Multimerin Binding Region within the C2 Domain of Human Factor V Using Constructs Generated by Alanine-Scanning and Site-Directed Mutagenesis.

Mutation of the Hydrophobic Residues in Factor Va2 C1 Domain Affects the Phosphatidylserine Mediated Prothrombin Activation.

Novel functional defect in factor V deficiency

Inhibitory Anti–Factor V Antibodies Bind to the Factor V C2 Domain and Are Associated With Hemorrhagic Manifestations

Studies of a Second Family With the Quebec Platelet Disorder: Evidence That the Degradation of the α-Granule Membrane and Its Soluble Contents Are Not Secondary to a Defect in Targeting Proteins to α-Granules

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only